Skip to main content

Peer Review reports

From: Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial

Original Submission
28 Aug 2022 Submitted Original manuscript
2 Nov 2022 Author responded Author comments - Dawei Yang
Resubmission - Version 2
2 Nov 2022 Submitted Manuscript version 2
30 Mar 2023 Reviewed Reviewer Report - Effat Davoudi-Monfared
2 May 2023 Reviewed Reviewer Report
30 May 2023 Author responded Author comments - Dawei Yang
Resubmission - Version 3
30 May 2023 Submitted Manuscript version 3
Publishing
1 Jun 2023 Editorially accepted
15 Jun 2023 Article published 10.1186/s40360-023-00678-7

You can find further information about peer review here.

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us